Unknown Manufacturer
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
It is designed to stimulate a patient's immune system to mount a specific and sustained response to disease. FavId is currently being developed for use following treatment with existing standards of care to extend time to disease progression in patients with B-cell non-Hodgkin's lymphoma
B-cell non-Hodgkin's lymphoma
